References
- Rabinovitch E, Harats D, Yaron P, Luvish T, Lidar M, Kedem R, et al. Familial Mediterranean fever gene and protection against asthma. Ann Allergy Asthma Immunol. 2007;99(6):517–21.
- Brenner-Ullman A, Melzer-Ofir H, Daniels M, Shohat M. Possible protection against asthma in heterozygotes for familial Mediterranean fever. Am J Med Genet. 1994;53(2):172–5.
- Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine. 2014;93(3):158–64.
- Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S. Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther. 2014;16(5):439.
- Dewey A, Dean T, Bara A, Lasserson TJ, Walters EH. Colchicine as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev. 2003(4):CD003273.
- Newman KB, Mason UG, Buchmeier A, Schmaling KB, Corsello P, Nelson HS. Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma. J Allergy Clin Immunol. 1997;99(2):176–8.
- Schwarz YA, Kivity S, Ilfeld DN, Schlesinger M, Greif J, Topilsky M, et al. A clinical and immunologic study of colchicine in asthma. J Allergy Clin Immunol. 1990;85(3):578–82.
- Bruchard M, Rebe C, Derangere V, Togbé D, Ryffel B, Boidot R, et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015;16(8):859–70.
- Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med. 2004;200(5):551–8.
- Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity. 2011;34(5):755–68.